CAPPED BONUS CERTIFICATE - MERCK Share Price

Certificat

DE000SU146G3

Delayed Deutsche Boerse AG 01:20:58 28/05/2024 am IST
163.9 EUR -0.01% Intraday chart for CAPPED BONUS CERTIFICATE - MERCK
Current month+11.24%
1 month+9.68%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
27/24/27 163.9 -0.01%
24/24/24 164 -0.53%
23/24/23 164.8 +1.26%
22/24/22 162.8 -0.26%
21/24/21 163.2 +0.28%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 01:20 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU146G
ISINDE000SU146G3
Date issued 13/11/2023
Strike 208
Maturity 21/03/2025 (298 Days)
Parity 1 : 1
Emission price 154.6
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 167.6
Lowest since issue 132.4

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.4 EUR
Average target price
183.6 EUR
Spread / Average Target
+9.66%
Consensus